Article
Biopharma 4.0 – Spearheading Digital Transformation in the Biopharmaceutical Industry
Summary: For Contract Development and Manufacturing Organizations (CDMOs), transitioning to Biopharma 4.0 is crucial – the data and expertise amassed by these manufacturers represent an integral asset for their customers working to innovate in an increasingly competitive and fast-paced market.
View Now
Webinars
Choose Your CDMO Partner Wisely-Lessons Learned to Accelerate Product Development
Listen in as Mike and Darren share how new modalities and manufacturing technologies have altered the partnership landscape between developers and CDMOs.
View Now
Webinars
Streamlining Process Characterization Toward Successful Validation Campaigns
Summary: In this webinar, we explore the drivers for process characterization and late-phase development including improving process understanding, enhancing robustness, and assurance that it delivers...
View Now
Article
Process Validation: A Critical Step in a Biopharmaceutical Product’s Lifecycle
Summary: Process validation, including process characterization, is a critical step in the successful commercialization of a new biopharmaceutical on its path to commercialization. As the program approaches commercial launch...
View Now
Executive Summary
Obstacles and Opportunities in Orphan Biologics-From Development to Production and Supply
Summary: In this article, experts detail how drug developers overcome obstacles that may complicate the launch of orphan drugs in order to meet their own needs and the needs of patients.
View Now
Offering Fact Sheet
SMARTag® ADC Technology
Summary: Catalent’s SMARTag platform technology offers ADC and biologics innovators a toolkit to develop optimized ADCs and bioconjugates.
View Now
Executive Summary
Developing the Next Big Vaccine Technologies
Summary: The field’s top experts weigh in on the technologies they are working on, including self-amplifying RNA, computer-designed nanoparticles, expanding mRNA processes and...
View Now
Webinars
The Post-COVID Supply Chain
Summary: During this panel discussion, executives share how their companies adapted to the challenges and what lessons they will take forward to ensure...
View Now
Webinars
Catalent’s Chair and CEO Shares His Views About Drug Development and Manufacturing in a Pandemic
Summary: In December 2021, John Chiminski was featured on the expert panel of STAT’s "A Look Ahead at Biotech in 2022" event, which focused on the ongoing battle against the SARS-CoV-2 virus and explored what might be in store for the biotech industry in the years to come.
View Now
Webinars
mRNA-A 20 Year Voyage to Patients
Summary: On December 13, 2021, EuropaBio hosted the final event of its 25th Anniversary programme with a focus on the story of mRNA.
View Now